Last reviewed · How we verify

NCT05572606

Treatment of Symptomatic Bloating Using a Novel Hypnotherapy Protocol

Completed NA Last updated 20 October 2025
What this trial tests

NA trial testing Hypnotherapy in Bloating in 27 participants. Completed in 1 January 2025.

Timeline
26 January 2023
Primary endpoint
1 January 2025
1 January 2025

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment27
Start date26 January 2023
Primary completion1 January 2025
Estimated completion1 January 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Bloating. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to evaluate if hypnotherapy delivered electronically will help with bloating symptoms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Digital Therapeutic Combining Hypnosis and Diaphragmatic Breathing Intervention for Functional Abdominal Bloating: A Feasibility Study.
    Wang XJ, Philpot L, Ebbert J, Dilmaghani S, et al · · 2025 · cited 2× · PMID 39835688 · DOI 10.14309/ctg.0000000000000811

Verify or expand the search:

Other trials of Hypnotherapy

Trials testing the same drug.

Other recruiting trials for Bloating

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05572606.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing